Literature DB >> 27065366

Neuropscyhological Complications of HIV Disease and Substances of Abuse.

Lisa R Norman1, Anil Kumar2.   

Abstract

In the last decade, it has become increasingly apparent that neuropsychological deficits and impairments are associated with HIV infection. Given that antiretroviral therapies have extended the life expectancy of HIV-infected persons, it becomes critical to focus on the physical and mental health of these patients. Understanding the neuropsychology of HIV disease can provide insight into improving mental health, functional capacity and overall quality of life for persons living with HIV/AIDS. Furthermore, clinicians may be better able to assist patients to manage their symptoms, thereby increasing the number of patients who are able to successfully maintain difficult treatment schedules. In addition, it is equally important to understand the potentially exacerbating effects of various factors. One such factor is substance abuse, which has been associated with various neuropsychological impairments, irrespective of the substance of abuse. Therefore, a more complete understanding of the effects of substance abuse on the progression of impaired cognitive processes and functioning can allow for an enhanced evaluation and management of those patients who live with HIV disease and who suffer from substance abuse disorders. As such, the present paper provides an overview of the neuropsychology of HIV and substance abuse, as well as of the available research that has examined the potential interaction effects between HIV disease and substance abuse. The implications of the findings as well as directions for future research are discussed.

Entities:  

Keywords:  AIDS; HIV; neuropsychology; substance abuse

Year:  2006        PMID: 27065366      PMCID: PMC4824002          DOI: 10.3844/ajidsp.2006.67.73

Source DB:  PubMed          Journal:  Am J Infect Dis        ISSN: 1553-6203


  72 in total

1.  Disruption of frontocerebellar circuitry and function in alcoholism.

Authors:  Edith V Sullivan; Antony J Harding; Roberta Pentney; Cynthia Dlugos; Peter R Martin; Mitchell H Parks; John E Desmond; S H Annabel Chen; Michelle R Pryor; Eve De Rosa; Adolf Pfefferbaum
Journal:  Alcohol Clin Exp Res       Date:  2003-02       Impact factor: 3.455

2.  Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects.

Authors:  A C Parrott; E Gouzoulis-Meyfrank; J Rodgers; N Solowij
Journal:  J Psychopharmacol       Date:  2004-12       Impact factor: 4.153

3.  Effect of substance abuse on visuographic function.

Authors:  T Amir; T Bahri
Journal:  Percept Mot Skills       Date:  1994-02

4.  Sensorimotor dysfunction in HIV/AIDS: effects of antiretroviral treatment and comorbid psychiatric disorders.

Authors:  Lance O Bauer; Natalie A Ceballos; John D Shanley; Leslie I Wolfson
Journal:  AIDS       Date:  2005-03-25       Impact factor: 4.177

5.  Neurocognitive deficits in cocaine users: a quantitative review of the evidence.

Authors:  Diana Jovanovski; Suzanne Erb; Konstantine K Zakzanis
Journal:  J Clin Exp Neuropsychol       Date:  2005-02       Impact factor: 2.475

6.  Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence.

Authors:  Victoria Di Sclafani; Marina Tolou-Shams; Leonard J Price; George Fein
Journal:  Drug Alcohol Depend       Date:  2002-04-01       Impact factor: 4.492

Review 7.  Neurogenic and psychogenic behavioral correlates of HIV infection.

Authors:  I Grant; J H Atkinson
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1990

8.  Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection.

Authors:  M P Heyes; R J Ellis; L Ryan; M E Childers; I Grant; T Wolfson; S Archibald; T L Jernigan
Journal:  Brain       Date:  2001-05       Impact factor: 13.501

9.  Alcohol-induced neurodegeneration: when, where and why?

Authors:  Fulton T Crews; Michael A Collins; Cynthia Dlugos; John Littleton; Lincoln Wilkins; Edward J Neafsey; Roberta Pentney; Lawrence D Snell; Boris Tabakoff; Jian Zou; Antonio Noronha
Journal:  Alcohol Clin Exp Res       Date:  2004-02       Impact factor: 3.455

10.  Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.

Authors:  E Gouzoulis-Mayfrank; B Thelen; S Maier; K Heekeren; K-A Kovar; H Sass; M Spitzer
Journal:  Neuropsychobiology       Date:  2002       Impact factor: 2.328

View more
  1 in total

Review 1.  An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research.

Authors:  Lisa R Norman; Michael Basso
Journal:  Curr Drug Abuse Rev       Date:  2015
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.